The study found that nearly one third of patients died within a few years of diagnosis.
What the Study Found
Researchers led by Imelda Coffi MD of Assistance Publique Hôpitaux de Paris reviewed electronic health records from the Greater Paris University Hospitals. They identified 1,320 patients who received a Korsakoff syndrome diagnosis between 2017 and 2022. During a median follow up of 3.1 years 30.2% of those patients died.
Several factors increased mortality risk. Malnutrition raised the risk by 54%. Alcoholic liver disease raised it by 45%. Male sex also raised the risk by 45%. Patients between 80 and 89 years old had twice the risk of younger patients.
Alcohol Use Disorder and Thiamine Deficiency
Korsakoff syndrome develops when the body lacks thiamine or vitamin B1. The brain needs thiamine to convert nutrients into energy. The condition often follows Wernicke encephalopathy. This acute neurological disorder can go undiagnosed or receive inadequate treatment.
High dose intravenous thiamine can treat Wernicke encephalopathy. However the treatment window can close quickly. Once memory damage develops, the condition becomes even harder to reverse.
The syndrome primarily damages episodic memory. Patients can otherwise remain alert and coherent. That combination can make the condition difficult to recognize.
In a well documented subgroup of 114 patients 61% had anterograde amnesia. This condition prevents people from forming new memories. Only 19% reported a history of Wernicke encephalopathy. That finding suggests that clinicians missed many precursor cases.
Diagnosis presents another challenge. Experts have not established any consensus criteria for the condition. Delays can also last from months to years.
Korsakoff syndrome does not affect only people who drink heavily. Chronic poor nutrition and eating disorders can also cause thiamine deficiency. Physicians at Mass General Brigham recently diagnosed Wernicke Korsakoff syndrome in a 62 year old breast cancer patient who did not drink alcohol.
Malnutrition likely contributed to her condition. Researchers have also identified a very small number of cases among patients who took semaglutide such as Wegovy or Ozempic.
Why Diagnosis Comes Too Late
The study demographics show a familiar pattern. The mean patient age was 62.9 years. Men accounted for 72.9% of the group. Alcohol use disorder affected 43.7% of patients. High blood pressure affected 22.1% while alcoholic liver disease affected 15.7%.
One finding stands out. Emergency departments became the entry point for care for 43.6% of patients. That pattern suggests healthcare providers often encountered patients after the disorder had progressed significantly.
What This Means for Treatment Seekers
The study highlights the importance of comprehensive care for treatment seekers. People can prevent thiamine deficiency and clinicians can treat its acute phase when they catch it early.
Programs that combine addiction treatment with medical evaluation, nutritional support and physician oversight can address several risks at once.
When you compare rehab options, ask whether each program includes medical screening and nutritional assessment during admission. A program that addresses overall health can identify problems that a program focused only on drinking may overlook.
Finding the Right Rehab
If you or someone you love drinks heavily, this finding offers another reason to seek help early. Evidence based alcohol use disorder treatment can include medically supervised detox, medication assisted treatment and behavioral therapy. Starting treatment earlier can provide more opportunities to address the medical and behavioral complications.
Rehab.com offers a directory of treatment centers nationwide. Profiles include information about levels of care and accepted insurance. Call
800-985-8516
( 
Sponsored Helpline )
to speak with a treatment advisor today and learn more about your options.
